Basis of Presentation (Details) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 15, 2021 |
Jun. 30, 2022
USD ($)
|
Jun. 30, 2021
USD ($)
|
Jun. 30, 2022
USD ($)
shares
|
Jun. 30, 2021
USD ($)
shares
|
|
| Anti-dilutive securities | |||||
| Reverse stock split ratio | 0.333 | ||||
| Loss on impairment of intangible asset and goodwill | $ | $ 0 | $ 0 | $ 0 | $ 0 | |
| Obalon Therapeutics Inc. | |||||
| Anti-dilutive securities | |||||
| Stock exchange ratio | 0.5367 | ||||
| Stock options | |||||
| Anti-dilutive securities | |||||
| Anti-dilutive securities (in shares) | 820,092 | 256,881 | |||
| Convertible preferred stock | |||||
| Anti-dilutive securities | |||||
| Anti-dilutive securities (in shares) | 38 | 742 | |||
| Warrants to purchase common stock | |||||
| Anti-dilutive securities | |||||
| Anti-dilutive securities (in shares) | 6,952,328 | 6,181,997 | |||